Biotech News

Flyte Aviation Reports Record Preliminary Third Quarter Revenue of $2.15 Million, Up 110% Quarter Over Quarter

Catheter Precision (VTAK)Catheter Precision2026-10-12 10:00 ESTEarnings

Flyte Aviation, Inc. (NYSE American: VJET), a technology-enabled private aviation company, today announced record preliminary third quarter 2026 revenue of approximately $2.15 million. This represents an increase of approximately 110%, quarter-over-quarter, compared with $1.02 million in the second quarter of 2026.

Related news

HYPRHyperfine2026-10-08 11:30 EST

Hyperfine Reports Record Preliminary Third Quarter Revenue of Approximately $6.0 Million & Reaffirms Full Year 2026 Revenue Outlook of Approximately $20 to $22 Million

XAIRBeyond Air2026-10-08 12:00 EST

Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026

IARTIntegra LifeSciences2026-10-02 12:05 EST

Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance

PLSEPulse Biosciences2026-10-22 20:05 EST

Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026

SGHTSight Sciences2026-10-21 20:05 EST

Sight Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026

OMOutset Medical2026-10-21 20:05 EST

Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026

STIMNeuronetics2026-10-21 12:30 EST

Neuronetics to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call

SENSSenseonics2026-10-21 12:00 EST

Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time

IARTIntegra LifeSciences2026-10-21 10:00 EST

Integra LifeSciences Reports Third Quarter 2026 Financial Results

TCMDTactile Systems Technology, Inc.2026-10-19 20:05 EST

Tactile Medical to Release Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026

View all latest news

Catheter Precision

Cardiac Electrophysiology and Aviation Company Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE. The company therefore operates through two distinct segments. VIVO Cardiac Mapping System VIVO is a non-invasive three-dimensional mapping system used...

Recent company news

VTAKCatheter Precision2026-10-20 20:20 EST

Flyte Aviation Establishes New B2B Distribution Channel, Launches Partner Portal

VTAKCatheter Precision2026-10-14 12:00 EST

Flyte Aviation Partners with The Philadelphia 76ers

VTAKCatheter Precision2026-10-12 10:00 EST

Flyte Aviation Reports Record Preliminary Third Quarter Revenue of $2.15 Million, Up 110% Quarter Over Quarter

VTAKCatheter Precision2026-10-05 08:15 EST

Flyte Aviation Launches Under NYSE American Ticker “VJET”

VTAKCatheter Precision2026-10-02 20:30 EST

Catheter Precision to Change its Name and Ticker Symbol to Flyte Aviation and “VJET” and Effect 1-for-10 Reverse Stock Split, Monday, October 5, at Market Open

Stock data

Close: 1.51 USD
Market cap: 2.58M USD
Exchange: NYSE
Sector: MedTech
Location: United States